| Authors: |
Landmesser U; Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité; Charité-Universitätsmedizin Berlin, German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Germany. Electronic address: ulf.landmesser@dhzc-charite.de., Laufs U; Department of Cardiology, Klinik und Poliklinik für Kardiologie, Leipzig University Hospital, Leipzig, Germany., Schatz U; Department of Internal Medicine III, University Hospital Carl Gustav Carus, Faculty of Medicine at the Technical University of Dresden, Dresden, Germany., Winzer EB; Department for Internal Medicine and Cardiology, Heart Center Dresden, University Clinic, Technische Universität Dresden, Dresden, Germany., Nowak B; Department of Cardiology, CardioVascular Center Bethanien (CCB), Frankfurt, Germany., Kassner U; Department of Endocrinology, Division of Lipid Disorders, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Gouni-Berthold I; Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Esteban A; Novartis Pharma AG, Basel, Switzerland., Lubyayi L; Novartis Pharmaceuticals UK Ltd, London, UK., Krueger A; Novartis Pharma AG, Basel, Switzerland., Streich JH; Novartis Pharma GmbH, Nuremberg, Germany., Hentschke C; Assya Achouba: Novartis Pharma AG, Basel, Switzerland., Achouba A; Assya Achouba: Novartis Pharma AG, Basel, Switzerland., Banach M; Faculty of Medicine, The John Paul II Catholic University of Lublin, Lublin, Poland; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Liverpool Centre for Cardiovascular Science (LCCS), Liverpool, UK. |
